The pharma industry is facing some difficult strategic choices. As the costs of R&D escalate, other more reliable revenue streams look increasingly attractive. What are the best bets? Will big pharma in its current incarnation even be around in ten years time? And will it be new business models or technological innovations that fundamentally change the industry? Every year, we identify those trends that have the potential to truly transform the pharmaceutical industry, bringing together leading thinkers and experts, who will unlock a fresh perspective. Now in its 18th year, our annual Pharma Summit will this year look at the emerging healthcare models and discuss what part pharma will play over the next five to ten years.